The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Association of tenofovir exposure with kidney disease risk in HIV infection
Open accessAbstract
OBJECTIVE: Despite widespread HAART use, HIV disease remains associated with increased risk of kidney disease. Whether tenofovir use is associated with higher risk of kidney disease is controversial. DESIGN: We evaluated the association of cumulative and ever exposure to tenofovir on kidney outcomes in 10,841 HIV-infected patients from the Veterans Health Administration who initiated antiretroviral therapy from 1997 to 2007. METHODS: Cox proportional hazards and marginal structural models evaluated associations between tenofovir and time to first occurrence of proteinuria (two consecutive urine dipstick measurements ≥30 mg/dl), rapid decline in kidney function (≥3 ml/min per 1.73 m annual decline), and chronic kidney disease (CKD; estimated glomerular filtration rate <60 ml/min per 1.73 m). RESULTS: Median follow-up ranged from 3.9 years (proteinuria) to 5.5 years (CKD), during which 3400 proteinuria, 3078 rapid decline, and 533 CKD events occurred. After multivariable adjustment, each year of exposure to tenofovir was associated with 34% increased risk of proteinuria [95% confidence interval (CI) 25-45, P < 0.0001], 11% increased risk of rapid decline (3-18, P = 0.0033), and 33% increased risk of CKD (18-51, P < 0.0001). Preexisting renal risk factors did not appear to worsen the effects of tenofovir. Other antiretroviral drugs showed weaker or inconsistent associations with kidney disease events. Among those who discontinued tenofovir use, risk of kidney disease events did not appear to decrease during follow-up. CONCLUSION: Tenofovir exposure was independently associated with increased risk for three types of kidney disease events, and did not appear to be reversible. Because subtle kidney function decline affects long-term morbidity and mortality, the balance between efficacy and probable adverse effects requires further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,782
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341 · cited 1×
“Prior to FDA approval, early TDF studies found no or only limited nephrotoxicity; these studies, however, excluded those with preexisting renal impairment and generally enrolled populations without other risk factors for kidney disease [6,7].”
BackgroundMocroft, A., Kirk, O., Reiss, P., De Wit, S., Sedlacek, D., Beniowski, M., Gatell, J., Phillips, A. N., Ledergerber, B., & Lundgren, J. D. (2010) · AIDS · doi:10.1097/qad.0b013e328339fe53 · Cited by 406
Rapid Kidney Function Decline and Mortality Risk in Older Adults
Rifkin, D. E., Shlipak, M. G., Katz, R., Fried, L. F., Siscovick, D., Chonchol, M., Newman, A. B., & Sarnak, M. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2212 · Cited by 375
Self-citationTenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
Hall, A. M., Hendry, B. M., Nitsch, D., & Connolly, J. O. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.01.022 · Cited by 373
Karras, A., Lafaurie, M., Furco, A., Bourgarit, A., Droz, D., Sereni, D., Legendre, C., Martinez, F., & Molina, J. (2003) · Clinical Infectious Diseases · doi:10.1086/368314 · Cited by 361
Nelson, M. R., Katlama, C., Montaner, J. S., Cooper, D. A., Gazzard, B., Clotet, B., Lazzarin, A., Schewe, K., Lange, J., Wyatt, C., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3280b07b33 · Cited by 352
Herlitz, L. C., Mohan, S., Stokes, M. B., Radhakrishnan, J., D'Agati, V. D., & Markowitz, G. S. (2010) · Kidney International · doi:10.1038/ki.2010.318 · Cited by 348
Veterans Aging Cohort Study (VACS): Overview and Description
Justice, A. C., Dombrowski, E., Conigliaro, J., Fultz, S. L., Gibson, D., Madenwald, T., Goulet, J., Simberkoff, M., Butt, A. A., Rimland, D., et al. (2006) · Medical Care · doi:10.1097/01.mlr.0000223741.02074.66 · Cited by 320
Gallant, J. E., Parish, M. A., Keruly, J. C., & Moore, R. D. (2005) · Clinical Infectious Diseases · doi:10.1086/428840 · Cited by 302
Renal Tubular Dysfunction Associated With Tenofovir Therapy: Report of 7 Cases
Peyri??re, H., Reynes, J., Rouanet, I., Daniel, N., de Boever, C. M., Mauboussin, J.-M., Leray, H., Moachon, L., Vincent, D., & Salmon-C??ron, D. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200403010-00007 · Cited by 262
Rodríguez‐Nóvoa, S., Labarga, P., Soriano, V., Egan, D., Albalater, M., Morello, J., Cuenca, L., González‐Pardo, G., Khoo, S., Back, D., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598507 · Cited by 241
Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection: A Randomized Trial
Squires, K., Pozniak, A. L., Pierone, G., Steinhart, C. R., Berger, D., Bellos, N. C., Becker, S. L., Wulfsohn, M., Miller, M. D., Toole, J. J., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00006 · Cited by 198
Tenofovir renal toxicity targets mitochondria of renal proximal tubules
Kohler, J. J., Hosseini, S. H., Hoying-Brandt, A., Green, E., Johnson, D. M., Russ, R., Tran, D., Raper, C. M., Santoianni, R., & Lewis, W. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.14 · Cited by 195
Choi, A. I., Li, Y., Deeks, S. G., Grunfeld, C., Volberding, P. A., & Shlipak, M. G. (2010) · Circulation · doi:10.1161/circulationaha.109.898585 · Cited by 170
Self-citationCardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
Choi, A. I., Vittinghoff, E., Deeks, S. G., Weekley, C. C., Li, Y., & Shlipak, M. G. (2011) · AIDS · doi:10.1097/qad.0b013e328347fa16 · Cited by 170
Self-citationVHA Enrollees' Health Care Coverage and Use of Care
Shen, Y., Hendricks, A., Zhang, S., & Kazis, L. E. (2003) · Medical Care Research and Review · doi:10.1177/1077558703060002007 · Cited by 162
Impact of Tenofovir on Renal Function in HIV-Infected, Antiretroviral-Naive Patients
Horberg, M. A., Tang, B. T., Towner, W. J., Silverberg, M. J., Bersoff‐Matcha, S. J., Hurley, L. B., Chang, J., Blank, J., Quesenberry, C. P., & Klein, D. B. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181be6be2 · Cited by 146
Petersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., Riley, E. D., & Bangsberg, D. R. (2007) · Clinical Infectious Diseases · doi:10.1086/521250 · Cited by 144
Patient- and provider-reported adherence
Wagner, J. H., Justice, A. C., Chesney, M. A., Sinclair, G. I., Weissman, S., & Rodriguez‐Barradas, M. C. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00450-4 · Cited by 139
Spectrum of chronic kidney disease in HIV‐infected patients
Campbell, L., Ibrahim, F., Fisher, M., Holt, S. G., Hendry, B., & Post, F. A. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00691.x · Cited by 132
Incomplete Reversibility of Tenofovir-Related Renal Toxicity in HIV-Infected Men
Wever, K., van Agtmael, M. A., & Carr, A. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181d05579 · Cited by 128
Dauchy, F., Lawson‐Ayayi, S., de la Faille, R., Bonnet, F., Rigothier, C., Mehsen, N., Miremont‐Salamé, G., Cazanave, C., Greib, C., Dabis, F., et al. (2011) · Kidney International · doi:10.1038/ki.2011.124 · Cited by 115
Cystatin C, Albuminuria, and 5-Year All-Cause Mortality in HIV-Infected Persons
Choi, A. I., Scherzer, R., Bacchetti, P., Tien, P. C., Saag, M. S., Gibert, C. L., Szczech, L. A. M., Grünfeld, C., & Shlipak, M. G. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.05.019 · Cited by 110
Self-citationBackus, L. I., Gavrilov, S., Loomis, T. P., Halloran, J. P., Phillips, B. R., Belperio, P. S., & Mole, L. A. (2009) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m3203 · Cited by 104
Martínez, E., Arranz, J. A., Podzamczer, D., Loncà, M., Sanz, J., Barragán, P., Ribera, E., Knobel, H., Roca, V., Gutiérrez, F., et al. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181aa12d5 · Cited by 84
HIV viremia and changes in kidney function
Longenecker, C. T., Scherzer, R., Bacchetti, P., Lewis, C. E., Grünfeld, C., & Shlipak, M. G. (2009) · AIDS · doi:10.1097/qad.0b013e32832a3f24 · Cited by 70
Self-citationPetersen, M. L., Wang, Y., van der Laan, M. J., & Bangsberg, D. R. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000248344.95135.8d · Cited by 57
Renal disease in HIV-infected individuals
Phair, J., & Palella, F. J. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283476bc3 · Cited by 57
Ando, M., Yanagisawa, N., Ajisawa, A., Tsuchiya, K., & Nitta, K. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr020 · Cited by 43
Irizarry-Alvarado, J. M., Dwyer, J. P., Brumble, L. M., Álvarez, S., & Mendez, J. (2009) · PubMed · Cited by 39
Izzedine, H., Thibault, V., Valantin, M., Peytavin, G., Schneider, L., & Benhamou, Y. (2010) · AIDS · doi:10.1097/qad.0b013e3283313f54 · Cited by 30
Manosuthi, W., Mankatitham, W., Lueangniyomkul, A., Prasithsirikul, W., Tantanathip, P., Suntisuklappon, B., Narkksoksung, A., Nilkamhang, S., & D, S. S. M. (2010) · AIDS Research and Therapy · doi:10.1186/1742-6405-7-37 · Cited by 15
Cited by
The end of AIDS: HIV infection as a chronic disease
Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,063
Self-citationSax, P. E., Wohl, D., Yin, M. T., Post, F., DeJesus, E., Saag, M., Pozniak, A., Thompson, M., Podzamczer, D., Molina, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60616-x · Cited by 601
Is HIV a Model of Accelerated or Accentuated Aging?
Pathai, S., Bajillan, H., Landay, A. L., & High, K. P. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt168 · Cited by 414
Ray, A. S., Fordyce, M. W., & Hitchcock, M. J. M. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2015.11.009 · Cited by 392
Kuhar, D. T., Henderson, D. K., Struble, K. A., Heneine, W., Thomas, V., Cheever, L. W., Gomaa, A., Panlilio, A. L., & US Public Health Service Working Group (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/672271 · Cited by 377
Metadata
- Authors
- Scherzer, R., Estrella, M., Li, Y., Choi, A. I., Deeks, S. G., Grunfeld, C., & Shlipak, M. G.
- Venue
- AIDS
- Published
- 2012-04-24
- Volume
- 26
- Issue
- 7
- Pages
- 867-875
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W1967879506
- Cited by
- 424
- References
- 34
- FWCI
- 31.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.